(R)-(+)-Atenolol,
(R)-Atenolol,
56715-13-0,
(+)-Atenolol,
R(+)-Atenolol,
UNII-YG132I00WY,
R-(+)-Atenolol,
(R)-2-(4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide,
YG132I00WY,
CHEBI:55352,
GEO-02767,
MFCD00074917,
2-(4-(2-Hydroxy-3-(Isopropylamino)propoxy)phenyl)ethanamide,
DSSTox_CID_25753,
DSSTox_RID_81097,
DSSTox_GSID_45753,
J-200025,
2-[4-({(2R)2-hydroxy-3-[(propan-2-yl)amino]propyl}oxy)phenyl]acetamide,
SMR000326747,
Atenolol, (+)-,
SR-01000075276,
Prenormin,
Totamol,
Vasaten,
Atenix,
2-[4-[(2R)-2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide,
2-{4-[(2R)-2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide,
NCGC00093636-03,
2TN,
CAS-56715-13-0,
(+)-(R)-Atenolol,
Prestwick0_000953,
Prestwick1_000953,
Prestwick2_000953,
Prestwick3_000536,
AC1L47EF,
AC1Q1Q9R,
(R)-(+)-Atenolol HCl,
Lopac0_000146,
SCHEMBL18120,
BSPBio_000551,
MLS001332497,
MLS001332498,
MLS002154070,
BIDD:GT0478,
SPBio_003095,
(+)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide,
BPBio1_000607,
CHEMBL1230004,
DTXSID0045753,
ZINC14007,
(R)-(+)-Atenolol, 99%,
HMS1570P08,
HMS2096L13,
HMS2235G14,
HMS3713L13,
Tox21_111211,
AKOS017343045,
Tox21_111211_1,
CCG-204241,
DB06987,
NCGC00015007-14,
NCGC00093636-04,
NCGC00093636-05,
AJ-08370,
A-142,
AB00513974,
EU-0100146,
FT-0662315,
Z1861,
AB00513974_06,
I05-2985,
SR-01000075276-1,
SR-01000075276-2,
BRD-K68075732-001-03-5,
UNII-50VV3VW0TI component METKIMKYRPQLGS-GFCCVEGCSA-N,
Benzeneacetamide, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, (R)-,
2-[4-({(2R)-2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]acetamide,
atenolol,
Atenololum,
Cuxanorm,
Selobloc,
Tenoblock,
Tenoretic,
Tenormin,
Myocord,
Atenol,
(R)-( )-Atenolol,
(S)-(-)-Atenolol,
C14H22N2O3,
CID180559,
C14-H22-N2-O3,
29122-68-7,